Salma Alawadi

Supported antineoplastic clinical trials in non‑Hodgkin lymphoma through protocol compliance and high‑quality data collection. Collaborated with cross‑functional teams to document and report safety in line with GCP standards. Gained broad insight into clinical study setup, monitoring, and data review of the clinical research.

Assisted in teaching undergraduate courses in molecular biology and neuroscience. Supervisied students in practical lab sessions, ensuring proper experimental technique and safety.

Investigated laboratory techniques such as performed cell culture and cytotoxicity assays. Contributed to qPCR‑based molecular analysis. Evaluated nanoparticle‑encapsulated drug candidates in neuroblastoma models, including in vivo studies to assess efficacy and safety in animal models. Co‑authored a peer‑reviewed publication on polycaprolactone/chitosan nanocomposites for targeted therapy.